Administration of nifedipine CR immediately after awakening prevents a morning surge in hypertensive patients. Case report of three cases

Blood Pressure, Supplement

Volumn 12, Issue 1, 2003, Pages 44-48

  Kawano, Hiroaki ^a   Ashizawa, Naoto ^b   Toda, Genji ^b   Seto, Shinji ^b   Yano, Katsusuke ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

Ambulatory blood pressure monitoring; Calcium antagonist; Hypertension; Morning surge

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; CALCIUM ANTAGONIST; CANDESARTAN; ENALAPRIL; FUROSEMIDE; LONG ACTING DRUG; METOPROLOL; NIFEDIPINE; SPIRONOLACTONE; TORASEMIDE; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; AROUSAL; ARTICLE; BLOOD PRESSURE MONITORING; CASE REPORT; CHRONOPHARMACOLOGY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HYPERTENSION; MALE; MORNING SURGE; PRIORITY JOURNAL; ANGINA PECTORIS; BLOOD; BLOOD PRESSURE; CIRCADIAN RHYTHM; DELAYED RELEASE FORMULATION; HEART RATE; PATHOPHYSIOLOGY;

ADULT; AGED; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; MALE; NIFEDIPINE; ANGINA PECTORIS; DELAYED-ACTION PREPARATIONS; HEART RATE;

EID: 0041914236     PISSN: 08038023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Graney WF. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension. Am J Med 1992; 93: 56-64S.
2. Grandinetti O, Feraco E. Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients. Clin Exp Hypertens 1993; 15 Suppl 1: 197-210.
3. Skoularigis J, Weinberg J, Strugo V, et al. Effect of isradipine in black patients with very severe hypertension. 24-hour ambulatory blood pressure monitoring and echocardiographic evaluation. Am J Hypertens 1994; 7: 1058-64.
4. Mallion JM, Baguet JP, Boutelant S, Tremel F, Siche JP, de Gaudemaris R. Second-generation calcium antagonists and ambulatory blood pressure monitoring. J Cardiovasc Pharmacol 1995; 25 Suppl 3: S17-22.
5. Zidek W, Spiecker C, Knaup G, Steindl L, Breuer HW. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group. Clin Ther 1995; 17: 686-700.
6. Podjarny E, Korzets Z, Bernheim J. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring. J Hum Hypertens 1996; 10 Suppl 3: S 153-6.
7. Ostergren J, Isaksson H, Brodin U, Schwan A, Ohman K. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension. Am J Hypertens 1998; 11(6 Pt 1): 690-6.
8. Yoshikawa H, Ohta A, Kasamatsu K, et al. Enhanced efficacy of nilvadipine in hypertensives whose raised ambulatory blood pressure is sustained during sleep. Am J Hypertens 1998; 11 (1 Pt 1): 122-4.
9. Tallian KB, Nahata MC, Turman MA, Mahan JD, Hayes JR, Mentser MI. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 1999; 13: 304-10.
10. Fogari R, Zoppi A, Mugellini A, Preti P, Corradi L, Lusardi P. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. Cardiovasc Drugs Ther 1999; 13: 243-8.
11. Nold G, Herholz C, Sturm M, Hopf R, Lemmer B. Ambulatory blood pressure profiles in essential hypertensives after treatment with a new once daily nifedipine formulation. J Hum Hypertens 1999; 13: 173-7.
12. Biston P, Melot C, Degaute JP, Clement D, Quoidbach A. Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study. Blood Press 1999; 8: 43-8.
13. Pannarale G, Puddu PE, Monti F, et al. Twenty-four-hour antihypertensive efficacy of felodipine 10mg extendedrelease: the Italian inter-university study. J Cardiovasc Pharmacol 1996; 27: 255-61.
14. Cummings DM, Amadio P, Nelson L, Fitzgerald JM. The role of calcium channel blockers in the treatment of essential hypertension. Arch Intern Med 1991; 151: 250-9.
15. Meyers MG, Toal CB. on behalf of the Switch Study Investigators. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. Can J Cardiol 1995; 11: 913-17.
16. Rahima-Maoz C, Grossman E, Nussinovitch N, Katz A, Rosenthal T. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy. Cardiology 1997; 88 Suppl 3: 43-6.
17. Nakamichi N, Yanagida T, Hikima Y, et al. Phase I study of nifedipine sustained-release formulation (BAY a 1040-OD Tablets): single administration study. Jpn Pharmacol Ther 1995; 23: 7-21 (in Japanese).
18. Nakamichi N, Yanagida T, Hikima Y, et al. Phase I study of nifedipine sustained-release formulation (BAY a 1040-OD Tablets): multiple administration study. Jpn Pharmacol Ther 1995; 23: 23-35 (in Japanese).
19. Ichihashi H. Formulation design nifedipine sustained-release tablets (Adalat CR tablet) based on coat-core technology of hydrophilic-matrix. Membrane 2000; 25: 60-6.
20. Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 1998; 3: 17-25.
21. White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit 2000; 5 Suppl 1: S17-23.
22. DeQuattro V, Lee DD, Allen J, Sirgo M, Plachetka J. Labetalol blunts morning pressor surge in systolic hypertension. Hypertension 1988; 11(2 Pt 2): 1198-201.
23. Weber MA. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? Am J Cardiol 2002; 89: 27-33A.
24. Grossman E, Messerli FH. Effect of calcium antagonists on sympathetic activity. Eur Heart J 1998; 19 Suppl F: F27-31.
25. Nakamura T, Honma H, Kohno I, Tsuruta I, Ishii H, Tamura K. Efficacy of manidipine on circadian blood pressure in essential hypertension. Blood Press 1992; 3 Suppl: 94-101.
26. Carr AA, Bottini PB, Prisant LM, et al. Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist. Am J Cardiol 1992; 69: 28-32E.
27. Feig PU, Gibson L, MacCarthy EP, Pettis PP, Schwartz L. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group. Clin Ther 1993; 15: 963-75.
28. Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig 1994; 72: 864-9.
29. Zanchetti A. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group. Drugs 1994; 48 Suppl 1: 23-30.
30. Zanchetti A. Trough: peak ratio of the blood pressure response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group. J Hypertens 1994; 12 Suppl: S97-106.